{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:10:02Z","timestamp":1756685402372,"version":"3.44.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,31]]},"DOI":"10.7759\/cureus.91353","type":"journal-article","created":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T23:33:38Z","timestamp":1756683218000},"source":"Crossref","is-referenced-by-count":0,"title":["Age and Clinical Activity Score (CAS): Key Predictive Factors for Non-shrinking Extraocular Muscles in Graves\u2019 Ophthalmopathy After Retrobulbar Injection of Glucocorticoids (GCs)"],"prefix":"10.7759","author":[{"given":"Yuying","family":"Xiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fagang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0905750","article-title":"Graves' ophthalmopathy","volume":"362","author":"Bahn RS","year":"2010","unstructured":"Bahn RS. Graves' ophthalmopathy. N Engl J Med. 2010, 362:726-38. 10.1056\/NEJMra0905750","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2011.11.007","article-title":"Evaluating Graves' orbitopathy","volume":"26","author":"Dolman PJ","year":"2012","unstructured":"Dolman PJ. Evaluating Graves' orbitopathy. Best Pract Res Clin Endocrinol Metab. 2012, 26:229-48. 10.1016\/j.beem.2011.11.007","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref3","article-title":"miRNA-21 promotes fibrosis in orbital fibroblasts from thyroid-associated ophthalmopathy","volume":"21","author":"Tong B","year":"2015","unstructured":"Tong B, Xiao MY, Zeng JX, Xiong W. miRNA-21 promotes fibrosis in orbital fibroblasts from thyroid-associated ophthalmopathy. Mol Vis. 2015, 21:324-34.","journal-title":"Mol Vis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2004.046193","article-title":"Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone","volume":"88","author":"Ebner R","year":"2004","unstructured":"Ebner R, Devoto MH, Weil D, et al.. Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone. Br J Ophthalmol. 2004, 88:1380-6. 10.1136\/bjo.2004.046193","journal-title":"Br J Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2020.8896","article-title":"Peribulbar injection of glucocorticoids for thyroid-associated ophthalmopathy and factors affecting therapeutic effectiveness: A retrospective cohort study of 386 cases","volume":"20","author":"Wang Y","year":"2020","unstructured":"Wang Y, Du B, Yang M, Zhu Y, He W. Peribulbar injection of glucocorticoids for thyroid-associated ophthalmopathy and factors affecting therapeutic effectiveness: A retrospective cohort study of 386 cases. Exp Ther Med. 2020, 20:2031-8. 10.3892\/etm.2020.8896","journal-title":"Exp Ther Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.5935\/0004-2749.20230063","article-title":"Adverse effects associated with peribulbar injection of triamcinolone for the treatment of thyroid eye disease: A retrospective case series","volume":"86","author":"Barlatay JM","year":"2023","unstructured":"Barlatay JM, Boza CP, Basso TO, Benavente M, Hern\u00e1ndez-Gauna GV, Premoli EJ. Adverse effects associated with peribulbar injection of triamcinolone for the treatment of thyroid eye disease: A retrospective case series. Arq Bras Oftalmol. 2023, 86:e20230063. 10.5935\/0004-2749.20230063","journal-title":"Arq Bras Oftalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3119","article-title":"Public health relevance of Graves' orbitopathy","volume":"98","author":"Ponto KA","year":"2013","unstructured":"Ponto KA, Merkesdal S, Hommel G, Pitz S, Pfeiffer N, Kahaly GJ. Public health relevance of Graves' orbitopathy. J Clin Endocrinol Metab. 2013, 98:145-52. 10.1210\/jc.2012-3119","journal-title":"J Clin Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.615993","article-title":"Epidemiology, natural history, risk factors, and prevention of Graves\u2019 orbitopathy","volume":"11","author":"Bartalena L","year":"2020","unstructured":"Bartalena L, Piantanida E, Gallo D, Lai A, Tanda ML. Epidemiology, natural history, risk factors, and prevention of Graves\u2019 orbitopathy. Front Endocrinol (Lausanne). 2020, 11:615993. 10.3389\/fendo.2020.615993","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-93275-9","article-title":"Prognostic factors of restrictive myopathy in thyroid eye disease","volume":"11","author":"Choi JH","year":"2021","unstructured":"Choi JH, Noh H, Kim YD, Woo KI. Prognostic factors of restrictive myopathy in thyroid eye disease. Sci Rep. 2021, 11:13781. 10.1038\/s41598-021-93275-9","journal-title":"Sci Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2010.04.004","article-title":"Do subtypes of graves' orbitopathy exist?","volume":"118","author":"Regensburg NI","year":"2011","unstructured":"Regensburg NI, Wiersinga WM, Berendschot TT, Potgieser P, Mourits MP. Do subtypes of graves' orbitopathy exist?. Ophthalmology. 2011, 118:191-6. 10.1016\/j.ophtha.2010.04.004","journal-title":"Ophthalmology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2004.02143.x","article-title":"Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies","volume":"61","author":"Eckstein AK","year":"2004","unstructured":"Eckstein AK, Plicht M, Lax H, et al.. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies. Clin Endocrinol. 2004, 61:612-8. 10.1111\/j.1365-2265.2004.02143.x","journal-title":"Clin Endocrinol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2007.02933.x","article-title":"Patients with severe Graves' ophthalmopathy have a higher risk of relapsing hyperthyroidism and are unlikely to remain in remission","volume":"67","author":"Eckstein AK","year":"2007","unstructured":"Eckstein AK, Lax H, L\u00f6sch C, et al.. Patients with severe Graves' ophthalmopathy have a higher risk of relapsing hyperthyroidism and are unlikely to remain in remission. Clin Endocrinol. 2007, 67:607-12. 10.1111\/j.1365-2265.2007.02933.x","journal-title":"Clin Endocrinol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.73.8.639","article-title":"Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: A novel approach","volume":"73","author":"Mourits MP","year":"1989","unstructured":"Mourits MP, Koornneef L, Wiersinga WM, Prummel MF, Berghout A, van der Gaag R. Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: A novel approach. Br J Ophthalmol. 1989, 73:639-44. 10.1136\/bjo.73.8.639","journal-title":"Br J Ophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2000.00959.x","article-title":"Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy","volume":"52","author":"Gerding MN","year":"2000","unstructured":"Gerding MN, van der Meer JW, Broenink M, Bakker O, Wiersinga WM, Prummel MF. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy. Clin Endocrinol. 2000, 52:267-71. 10.1046\/j.1365-2265.2000.00959.x","journal-title":"Clin Endocrinol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2470","article-title":"A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy","volume":"95","author":"Lytton SD","year":"2010","unstructured":"Lytton SD, Ponto KA, Kanitz M, Matheis N, Kohn LD, Kahaly GJ. A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy. J Clin Endocrinol Metab. 2010, 95:2123-31. 10.1210\/jc.2009-2470","journal-title":"J Clin Endocrinol Metab"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01353-y","article-title":"Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves' orbitopathy","volume":"44","author":"Nicol\u00ec F","year":"2021","unstructured":"Nicol\u00ec F, Lanzolla G, Mantuano M, et al.. Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves' orbitopathy. J Endocrinol Invest. 2021, 44:581-5. 10.1007\/s40618-020-01353-y","journal-title":"J Endocrinol Invest"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2004.050807","article-title":"Quantification of cells expressing the thyrotropin receptor in extraocular muscles in thyroid associated orbitopathy","volume":"89","author":"Boschi A","year":"2005","unstructured":"Boschi A, Daumerie Ch, Spiritus M, et al.. Quantification of cells expressing the thyrotropin receptor in extraocular muscles in thyroid associated orbitopathy. Br J Ophthalmol. 2005, 89:724-9. 10.1136\/bjo.2004.050807","journal-title":"Br J Ophthalmol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2003.01708.x","article-title":"TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients","volume":"58","author":"Wakelkamp IM","year":"2003","unstructured":"Wakelkamp IM, Bakker O, Baldeschi L, Wiersinga WM, Prummel MF. TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients. Clin Endocrinol. 2003, 58:280-7. 10.1046\/j.1365-2265.2003.01708.x","journal-title":"Clin Endocrinol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2011.10.003","article-title":"Immunopathogenesis of Graves' ophthalmopathy: The role of the TSH receptor","volume":"26","author":"Iyer S","year":"2012","unstructured":"Iyer S, Bahn R. Immunopathogenesis of Graves' ophthalmopathy: The role of the TSH receptor. Best Pract Res Clin Endocrinol Metab. 2012, 26:281-9. 10.1016\/j.beem.2011.10.003","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2813","article-title":"Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease","volume":"91","author":"Eckstein AK","year":"2006","unstructured":"Eckstein AK, Plicht M, Lax H, et al.. Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease. J Clin Endocrinol Metab. 2006, 91:3464-70. 10.1210\/jc.2005-2813","journal-title":"J Clin Endocrinol Metab"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-022-05627-4","article-title":"Clinical profile of 80-year-old and older thyroid eye disease patients","volume":"260","author":"Levy N","year":"2022","unstructured":"Levy N, Leiba H, Landau K, Zloto O, Huna-Baron R. Clinical profile of 80-year-old and older thyroid eye disease patients. Graefes Arch Clin Exp Ophthalmol. 2022, 260:2727-36. 10.1007\/s00417-022-05627-4","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s12938-023-01073-3","article-title":"The significance of ophthalmological features in diagnosis of thyroid-associated ophthalmopathy","volume":"22","author":"Huang X","year":"2023","unstructured":"Huang X, Tang W, Shen Y, et al.. The significance of ophthalmological features in diagnosis of thyroid-associated ophthalmopathy. Biomed Eng Online. 2023, 22:7. 10.1186\/s12938-023-01073-3","journal-title":"Biomed Eng Online"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-020-01246-7","article-title":"Clinical features and clinical course of thyroid-associated ophthalmopathy: A case series of 3620 Chinese cases","volume":"35","author":"Du B","year":"2021","unstructured":"Du B, Wang Y, Yang M, He W. Clinical features and clinical course of thyroid-associated ophthalmopathy: A case series of 3620 Chinese cases. Eye (Lond). 2021, 35:2294-301. 10.1038\/s41433-020-01246-7","journal-title":"Eye (Lond)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000002501","article-title":"Association of patient age and the thyroid eye disease-clinical activity score","volume":"39","author":"North VS","year":"2023","unstructured":"North VS, Zhou HW, Tran AQ, Godfrey KJ, Kazim M. Association of patient age and the thyroid eye disease-clinical activity score. Ophthalmic Plast Reconstr Surg. 2023, 39:S46-50. 10.1097\/IOP.0000000000002501","journal-title":"Ophthalmic Plast Reconstr Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/405281-age-and-clinical-activity-score-cas-key-predictive-factors-for-non-shrinking-extraocular-muscles-in-graves-ophthalmopathy-after-retrobulbar-injection-of-glucocorticoids-gcs","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T23:33:38Z","timestamp":1756683218000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/405281-age-and-clinical-activity-score-cas-key-predictive-factors-for-non-shrinking-extraocular-muscles-in-graves-ophthalmopathy-after-retrobulbar-injection-of-glucocorticoids-gcs"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,31]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.91353","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,31]]}}}